| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |